The EMEA Surgical Microscopes Market size is expected to reach USD 612.7 million by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.5% from 2021 to 2028. Technological advancements have enabled companies to design integrated surgical systems to streamline the workflow of surgical practices in hospitals and outpatient surgical centers. For example, the digitalization of surgical microscopes has transformed their quality and effectiveness. Key players in the region are conducting research activities to improve surgery efficiency. In November 2020, Leica Microsystems released Proveo 8 ophthalmic microscope, which was built around EnFocus intraoperative Optical Coherence Tomography (OCT) system. This system is expected to enhance the preoperative assessment and intraoperative tissue reaction for complex retinal surgeries. The COVID-19 pandemic led to the temporary suspension of company operations leading to disruption of the supply chain and a loss of revenue reported by manufacturers.
However, most of the companies have resumed their business operations and are expected to stabilize the market demand. The hospitals segment led the end-use segment in 2020. However, the physician clinics and other settings end-use segment is expected to exhibit the fastest CAGR during the forecast period. The growth can be credited to the high demand for advanced medical care in developed countries, such as Italy and France, and patient willingness to pay more for advanced surgical procedures for faster recovery & shorter hospital stays. In Europe, the U.K. is expected to grow at the fastest CAGR during the forecast period due to the high number of surgeries. For instance, according to the 2013 Operating Theatre project by NHS Benchmarking Network, around 10 million procedures are performed each year in England in just over 3,000 operating rooms. Related Press Release@ EMEA Surgical Microscopes Market Report EMEA Surgical Microscopes Market Report Highlights
0 Comments
The North America Non-Invasive Aesthetic Treatment Market size is expected to reach USD 46.07 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2021 to 2028. Non-invasive aesthetic treatments are procedures that do not require surgical intervention, have minimal downtime, lower risks of complications, and lower cost of treatment. The market growth is attributed to the rising demand for fillers and injectable including Botox as a result of the increasing target population across the globe. The demand for anti-aging aesthetic solutions that are non-invasive has escalated due to the increasing geriatric population pool.
According to the American Society of Plastic Surgeons (ASPS), high growth was observed in facial rejuvenation procedures, and the number of botulinum toxin type A procedures was the highest, accounting for over 7.7 million injections (Botox, Dysport, Xeomin) in 2019. It was also noted that in 2019, around 4,73,354 botulinum toxin filler procedures were performed on men in the U.S. This indicates that demand for the procedure is rapidly increasing among men. The U.S is among the top countries to carry out non-invasive aesthetic treatments globally as the acceptance towards advanced procedures is higher in the country. Moreover rising disposable income, superior medical infrastructure, the prevalence of skin conditions, and a large pool of aesthetic professionals are expected to boost the market growth. In the light of COVID-19, the global non-invasive aesthetic treatment market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended. The American Society of Plastic Surgeons stated that the pandemic reduced the overall uptake of aesthetic treatments; however, it will be the reason for an upsurge in demand for cosmetic procedures in the coming years, which is expected to rise even higher than previous numbers. Related Press Release@ North America Non-invasive Aesthetic Treatment Market Report North America Non-invasive Aesthetic Treatment Market Report Highlights
The global Healthcare ERP Consulting Services Market size is expected to reach USD 7.4 billion by 2028 and is expected to grow at a CAGR of 9.2% over the forecast period, according to a new report by Grand View Research, Inc., The growing healthcare expenditure and rising adoption levels of advanced technological solutions are driving facilities to successfully implement enterprise resource planning (ERP) solutions. The growing need to amalgamate multiple software solutions and applications running a facility under a single integrated database to enhance operational & financial efficiency is expected to drive the demand for consulting services in the market. Several healthcare organizations and facilities are contributing to the growing demand for ERP systems to integrate their business functionalities and enhance operational outcomes.
The rising awareness level of the organizations about the benefits associated with these solutions, such as remote location access of centralized data and better data management, is driving the adoption of ERP systems. The growing demand for consulting and strategic advising before and throughout the implementation of these solutions is driving the market growth. Adaption to the changes in business operations and training of advanced functions is a growing need of healthcare organizations and is provided by these consultancies and vendors, which is expected to propel market growth. Through the consultancy services, organizations can better understand the complexity of the solutions, the organization’s size & scope, the type of modules being implemented, and the number of external resources required. The implementation segment dominated the market with the growing need to understand the complexity of solutions before adoption. Implementation services are provided by software vendors, staffing firms, or business transformation leadership firms. However, the training and education segment is expected to grow significantly due to the provision of end-user training workshops in addition to implementation services for healthcare organizations adopting ERP solutions. The healthcare providers segment is anticipated to record the fastest growth owing to the growing need to improve operational & financial outcomes of the organization. Related Press Release@ Healthcare ERP Consulting Services Market Report Healthcare ERP Consulting Services Market Report Highlights
The global Radiology As A Service Market size is expected to reach USD 4.7 billion by 2028, registering a CAGR of 20.3% over the forecast period, according to a new report by Grand View Research, Inc. The increasing number of medical images and low availability of radiologists around the globe are the factors propelling the market growth over forecast years. According to the report published by the National Health Service (NHS) England, nearly 42.7 million medical images were reported in 2018 compared to 42.1 million in 2017, which indicates an increase of 1.4% yearly. The radiology as a service model provides quality diagnostic imaging services through teleradiology, technology management, cloud-based imaging, and consulting services via trained professionals. radiology as a service offers 24/7 service support to patients and radiologists across the globe. Increasing healthcare expenditure and the growing adoption of advanced cloud-based platforms are anticipated to accelerate the market growth over the forecast years.
The teleradiology service segment held the largest revenue share in 2020. Lack of the required number of radiologists and surge in the produced number of radiology images are accounted for the highest market share of this segment. The radiology as a service model allows 24/7 access to the latest medical imaging service via teleradiology to healthcare providers. Teleradiology covers services, such as reads and reporting. It provides the best possible diagnosis at a significantly lower cost. It involves the remote interpretation of a patient’s medical image generated from different modalities, such as X-ray, CT, MRI, and others, by the radiologists without their physical presence in the same location as the patient. Furthermore, the adoption of advanced technology in medical imaging has grown in the last five years at a lucrative rate. It is, in turn, responsible for the growing industry consolidation activities of the key market players in the teleradiology market. In March 2019, Koninklijke Philips N.V. acquired Direct Radiology’s teleradiology platform, which indicates the surging focus among large global market players regarding the expansion of its teleradiology portfolio. The hospital end-user segment accounted for the highest revenue share in 2020. The rising number of imaging procedures performed in hospitals and the increasing investments by hospitals to provide quality diagnostic imaging services are the major factors responsible for the highest revenue share of the segment. Moreover, increasing adoption of advanced imaging modalities and high patient visits to the hospital for medical imaging than radiology clinics and diagnostic imaging centers are also expected to drive the segment. Furthermore, the shortage of radiologists in hospitals and increasing radiology procedures in healthcare facilities, such as hospitals and clinics, are expected to support the growth of this end-user segment. North America was the leading regional market in 2020. The increasing number of service providers and growing awareness for the adoption of advanced technology are the major factors anticipated to maintain the dominance of this regional market over the forecast years. In addition, well-developed healthcare infrastructure, government support, and increasing demand for radiology as a service are projected to drive the market in this region. However, Asia Pacific is expected to grow at the highest CAGR from 2021 to 2028. It can be attributed to a growing consumer base, supportive government initiatives for modernizing the healthcare infrastructure, and increasing awareness in developing countries. Related Press Release@ Radiology as A Service Market Report Radiology As A Service Market Report Highlights
Automated Suturing Devices Market: Future Trends, Revenue Growth & Leading Players, Forecast To 20281/28/2022 The global Automated Suturing Devices Market size is expected to reach USD 5.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2021 to 2028. The factors influencing market growth include the increasing prevalence of chronic disorders, the growing geriatric population, rising preference of minimally invasive surgeries over traditional methods, growing technological advancements, and novel innovations in surgical equipment is also propelling the growth. However, lower penetration of automated suturing devices in developing economies and a lack of skilled professionals are expected to hinder market growth.
The increasing prevalence of minimally invasive surgeries for the preventive treatment of chronic disorders such as cardiac, orthopedic, gastrointestinal, and gynecological surgeries is expected to fuel market growth. Minimally invasive surgeries have advantages such as safety, shorter hospital stay and recovery time, and an overall reduction in hospital bills. These minimally invasive surgeries are economically viable alternatives to open or traditional surgeries. Technological advancements in minimally invasive surgeries and the introduction of new products in the market are among factors expected to drive the market. Furthermore, the increasing geriatric population leads to a heavy financial burden on the global healthcare system. According to Population Reference Bureau, in the U.S., the number of people aged 65 years and above is expected to reach 95 million by 2060. Such a sudden increase in geriatrics is expected to increase the demand for automated suturing devices for preventive surgeries and which in turn, fuels market growth. Increasing number of initiatives being undertaken by governments and nonprofit organizations to increase awareness about minimally invasive surgeries is expected to boost the adoption of automated suturing devices used for preventive treatment. Related Press Release@ Automated Suturing Devices Market Report Automated Suturing Devices Market Report Highlights
North America Unit Dose Manufacturing Market: Industry Demand, Analysis and Future Trends 20281/27/2022 The North America Unit Dose Manufacturing Market size is expected to reach USD 21.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. The rapidly growing pharmaceutical industry and rising demand for unit doses are factors driving the market.
Single-dose packaging has certainly become one of the most popular recent trends. The most obvious benefit is its ease of use and improved medication management, as they can be prescribed by the unit, ensuring that the person taking it does not exceed the prescribed dose. Stick packs are unique in the way that they can be used to package a variety of items, both dry and wet. Measuring cups, teaspoons, tablespoons, and multi-dose containers for oral liquids and eye drops have been already seen. The current patient is seeking convenience. Doctors are also appreciating the importance of unit dose in prescription writing since it allows them to prescribe controlled substance oral liquid without concern of abuse as unit doses address the issue. It also enables pharmacists to store oral liquids in a secure manner, which is a significant additional benefit. Nearly every single unit dose oral solid or multiple-dose oral liquid could be transformed to a unit dose oral liquid due to this innovation. However, owing to the COVID-19 pandemic's repercussions, the unit dose manufacturing market increased at a modest 11.0% year over year in 2020. By the end of 2020, the market started to recover. COVID-19-related illnesses are being treated using unit dosages. Hospitals have updated and implemented various new standard operating procedures to protect both patients and healthcare workers. As a consequence, it's crucial to consider out viral transmission by airborne transmission or direct contact. When unit dose medicines are used, some of the risks involved with handling and pouring doses from the same bottle are reduced. Related Press Release@ North America Unit Dose Manufacturing Market Report North America Unit Dose Manufacturing Market Report Highlights
The global Healthcare ERP Market size is expected to reach USD 10.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. Healthcare organizations are under pressure to adopt technological solutions to curb the rising expenditures, ineffective hospital service management, rising workforce shortage, and growing patient population. The rising awareness regarding benefits associated with adopting ERP systems, such as high-quality care delivery solutions, eliminating back-end manual activities, and minimizing operational expenses, contribute to the healthcare enterprise resource planning market growth.
The growing demand for ERP systems from small and medium businesses to enhance business processes and outcomes are driving the market. Seamless access to centralized data from remote locations improves the functioning and data management of the organization. The COVID-19 pandemic exposed the shortcomings of the existing systems adopted by healthcare organizations. During the pandemic, several businesses began adopting ERP systems to automate and digitalize their business processes and streamline their workflows to enhance their productivity and efficiency. The finance and billing function segment dominated the market in 2020 owing to the growing need to amalgamate the front-end revenue cycle management processes, such as patient access, with back-end activities such as claims management. The inventory and material management segment is expected to grow significantly over the forecast period due to the feature of real-time access to manufacturing and supply chain management. The on-premises deployment segment dominated the market in 2020 due to minimizing costs and ease of access. The cloud deployment segment is expected to grow lucratively over the forecast period owing to the growth of cloud computing and improved accessibility of the internet. North America dominated the market in 2020 due to rising adoption rates of advanced ERP systems and the emergence of AI-empowered solutions, coupled with infrastructure development. Asia Pacific is expected to register a significant growth rate over the forecast period owing to the emergence of start-ups providing AI-powered ERP systems, growing public and private partnerships to promote healthcare IT infrastructure, and availability of an economical high-skilled workforce. Related Press Release@ Healthcare ERP Market Report Healthcare ERP Market Report Highlights
The global Hair Restoration Market size is anticipated to reach USD 13.6 billion by 2028, according to the new report of Grand View Research, Inc. The market is expected to expand at a CAGR of 15.4% from 2021 to 2028. Hair restoration technique which includes surgical as well as a non-invasive treatment option is an effective procedure to increase hair thickness, fill in a receding hairline, and treat baldness as well as severe alopecia.
According to the American Academy of Dermatology, androgenic alopecia is the most common cause of hair loss in both men and women. According to the American Hair Loss Association, 95 % of hair loss in men is caused by androgenetic alopecia and around 40% of men notice symptoms of baldness by the age of 40. The market is currently witnessing a surge in treatment adoption due to high psychological stress, poor dietary habits, reduced nutritional levels with age progression, and increasing hormonal changes due to lifestyle shifts among the global population. This surge can also be due to the increased success rate of the transplantation procedures and technological advancement in the field of less invasive hair repair. In the light of COVID-19, the market was hampered as the footfall of patient appointments for surgical Follicular Unit Extraction (FUE) or Follicular Unit Transplantation (FUT) treatments was temporarily suspended. However since the government in many countries has allowed resuming elective surgical procedures, clinics have also started hair transplant procedures again and international organizations like the International Society of Hair Restoration Surgery (ISHRS) has set strict protocols for resuming hair restoration practices as well as offer patient guidance in finding hair repair clinics deemed. Related Press Release@ Hair Restoration Market Report Hair Restoration Market Report Highlights
The global Veterinary Endoscopes Market size is anticipated to reach USD 314.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a significant CAGR of 6.6% from 2021 to 2028. The key factors driving the growth include rising diagnostic and interventional procedures in companion as well as livestock animals and technological advancements.
The COVID-19 pandemic adversely impacted the market. Manufacturers and other market participants registered low demand and sales due to several challenges such as supply chain bottlenecks, reduced sales and marketing activities, and movement restrictions. Lockdown measures implemented at national and regional levels, in particular, led to reduced patient volume at veterinary hospitals and clinics. This dampened the demand for veterinary equipment including endoscopes. According to an April 2020 survey of veterinary practice owners conducted by the American Veterinary Medical Association, almost all respondents experienced a decrease in client traffic. Practice owners reported an estimated average monthly cash shortfall of about USD 17,000 due to a decline in revenue and costs incurred to ensure continuity of operations. However, the patient volume and sales started to recover during the latter half of 2020, as movement restrictions were eased. Technological advancements in veterinary endoscopes and growing demand for less painful, minimally invasive procedures for pets by pet parents are expected to fuel the growth of the market during the forecast period. The German company, KARL STORZ SE & Co. KG, for instance, offers an extensive portfolio of rigid and flexible veterinary endoscopes that include large animal videoendoscopes, Hopkins telescope, EquiVeo videoendoscope, uretero-reno-fiberscopes, otoscopes, small animal fiberscopes, hysteroscope, multi-purpose rigid telescopes, and others. These endoscopes are designed to serve the needs of different procedures and in animals of varying sizes. Related Press Release@ Veterinary Endoscopes Market Report Veterinary Endoscopes Market Report Highlights
The global Buccal Drug Delivery Systems Market size is expected to reach USD 5.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2021 to 2028. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing.
Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gainsdue to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022. Related Press Release@ Buccal Drug Delivery Systems Market Report Buccal Drug Delivery Systems Market Report Highlights
|
Archives
October 2023
|